Metal-Based Drugs publishes research on all aspects concerning the interaction of metals with diseases such as cancer, infection, inflammation, and with cardiovascular, CNS and metabolic diseases. The journal accepts papers on the synthesis and characterization, on preclinical activity, from the fate in living organisms to their mechanisms of action including the physiological effects and toxicity, and on clinical therapeutics of chemical structures based on metals and useful for the therapy or for the diagnosis of human diseases. Metal-Based Drugs is a multidisciplinary and authoritative reference on the role and on the use of metals in medicine. Metal-Based Drugs puts emphasis on all the metals and on metal compounds characterized and synthesized to fit with the modern aspects of molecular diagnosis and disease control, particularly on nanotechnologies and on the control of genes and of gene expressions. Metal-Based Drugs will also stimulate structure-activity relationships studies of cellular and molecular targeting of metal compounds.